Furthermore, the nanodrug successfully avoids being pumped out of cells by Pgp protein in Pgp-overexpressing drug-resistant cancer cells, allowing the nanodrug to maintain its high cytotoxicity (Fig 8). The gene discussed is PGP; the disease is cancer.